Synergistic renal effects of RS-10085, an ace inhibitor, and fenoldopam, a DA1 agonist, in the rat.
McClelland
D L
DL
Institute of Pharmacology, Syntex Research, Palo Alto, California 94304.
Rosenkranz
R P
RP
D000806:Angiotensin-Converting Enzyme Inhibitors / Q000494:pharmacology*; D000818:Animals; D001552:Benzazepines / Q000494:pharmacology*; D001794:Blood Pressure / Q000187:drug effects; D004357:Drug Synergism; D018818:Fenoldopam; D006339:Heart Rate / Q000187:drug effects; D007546:Isoquinolines / Q000494:pharmacology*; D007668:Kidney / Q000187:drug effects / Q000502:physiology*; D008297:Male; D051381:Rats; D011919:Rats, Inbred Strains; D011954:Receptors, Dopamine / Q000187:drug effects / Q000502:physiology; D017447:Receptors, Dopamine D1; D012016:Reference Values; D012079:Renal Circulation / Q000187:drug effects; D044005:Tetrahydroisoquinolines; D014655:Vascular Resistance / Q000187:drug effects
D000806:Angiotensin-Converting Enzyme Inhibitors; D001552:Benzazepines; D007546:Isoquinolines; D011954:Receptors, Dopamine; D017447:Receptors, Dopamine D1; D044005:Tetrahydroisoquinolines; D018818:Fenoldopam; C058302:moexipril